Kenton Kimmel

As CTO and co-founder of Newlight, Kenton has over 17 years of industrial experience in chemical, process, electrical, mechanical, and automation engineering. Kenton has been instrumental in the design, scale-up, and optimization of the company’s biomaterial manufacturing technology, including the engineering, construction, commissioning, and optimization of the company’s production lines. Prior to his work at Newlight, Kenton held a position in the In Vitro Microbiology Group at Allergan Pharmaceuticals where he conducted research on genetic markers and gene expression of potent neurotoxins for use in cosmetic surgery. Kenton graduated from Northwestern University with a Biomedical Engineering B.S.E degree, double specializing in Biomaterials & Biotechnology and Transport Processes & Tissue Engineering.